CTNA1_MOUSE - dbPTM
CTNA1_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CTNA1_MOUSE
UniProt AC P26231
Protein Name Catenin alpha-1
Gene Name Ctnna1
Organism Mus musculus (Mouse).
Sequence Length 906
Subcellular Localization Cytoplasm, cytoskeleton. Cell junction, adherens junction. Cell membrane
Peripheral membrane protein
Cytoplasmic side. Cell junction. Found at cell-cell boundaries and probably at cell-matrix boundaries.
Protein Description Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical actin was found to be much more dynamic than E-cadherin/catenin complexes and CTNNA1 was shown not to bind to F-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. The homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the Arp2/3 complex for binding to actin filaments. May play a crucial role in cell differentiation..
Protein Sequence MTAVHAGNINFKWDPKSLEIRTLAVERLLEPLVTQVTTLVNTNSKGPSNKKRGRSKKAHVLAASVEQATENFLEKGDKIAKESQFLKEELVVAVEDVRKQGDLMKSAAGEFADDPCSSVKRGNMVRAARALLSAVTRLLILADMADVYKLLVQLKVVEDGILKLRNAGNEQDLGIQYKALKPEVDKLNIMAAKRQQELKDVGNRDQMAAARGILQKNVPILYTASQACLQHPDVAAYKANRDLIYKQLQQAVTGISNAAQATASDDAAQHQGGSGGELAYALNNFDKQIIVDPLSFSEERFRPSLEERLESIISGAALMADSSCTRDDRRERIVAECNAVRQALQDLLSEYMGNAGRKERSDALNSAIDKMTKKTRDLRRQLRKAVMDHVSDSFLETNVPLLVLIEAAKNGNEKEVKEYAQVFREHANKLIEVANLACSISNNEEGVKLVRMSASQLEALCPQVINAALALAAKPQSKLAQENMDLFKEQWEKQVRVLTDAVDDITSIDDFLAVSENHILEDVNKCVIALQEKDVDGLDRTAGAIRGRAARVIHVVTSEMDNYEPGVYTEKVLEATKLLSNTVMPRFTEQVEAAVEALSSDPAQPMDENEFIDASRLVYDGIRDIRKAVLMIRTPEELDDSDFETEDFDVRSRTSVQTEDDQLIAGQSARAIMAQLPQEQKAKIAEQVASFQEEKSKLDAEVSKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVISAAKKIAEAGSRMDKLGRTIADHCPDSACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELVVSGVDSAMSLIQAAKNLMNAVVQTVKASYVASTKYQKSQGMASLNLPAVSWKMKAPEKKPLVKREKQDETQTKIKRASQKKHVNPVQALSEFKAMDSI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MTAVHAGNI
------CCCEECCCC
37.07-
2Phosphorylation------MTAVHAGNI
------CCCEECCCC
37.0728576409
12UbiquitinationHAGNINFKWDPKSLE
ECCCCCCCCCCCCHH
46.3122790023
16UbiquitinationINFKWDPKSLEIRTL
CCCCCCCCCHHHHHH
66.2622790023
34PhosphorylationRLLEPLVTQVTTLVN
HHHHHHHHHHHHHHC
25.6327717184
37PhosphorylationEPLVTQVTTLVNTNS
HHHHHHHHHHHCCCC
12.4727717184
38PhosphorylationPLVTQVTTLVNTNSK
HHHHHHHHHHCCCCC
29.8327717184
42PhosphorylationQVTTLVNTNSKGPSN
HHHHHHCCCCCCCCC
33.1329514104
44PhosphorylationTTLVNTNSKGPSNKK
HHHHCCCCCCCCCCC
36.6328978645
45UbiquitinationTLVNTNSKGPSNKKR
HHHCCCCCCCCCCCC
76.5322790023
48PhosphorylationNTNSKGPSNKKRGRS
CCCCCCCCCCCCCCC
70.7029514104
50UbiquitinationNSKGPSNKKRGRSKK
CCCCCCCCCCCCCCH
48.46-
57UbiquitinationKKRGRSKKAHVLAAS
CCCCCCCHHHHHHHH
45.0022790023
75UbiquitinationATENFLEKGDKIAKE
HHHHHHHHHHHHHHH
74.6522790023
81UbiquitinationEKGDKIAKESQFLKE
HHHHHHHHHHHHHHH
62.4622790023
116S-palmitoylationGEFADDPCSSVKRGN
CCCCCCCCHHHHHHH
6.4428526873
117PhosphorylationEFADDPCSSVKRGNM
CCCCCCCHHHHHHHH
43.4825338131
118PhosphorylationFADDPCSSVKRGNMV
CCCCCCHHHHHHHHH
38.0725195567
163UbiquitinationVVEDGILKLRNAGNE
CCCCCEEEECCCCCC
43.4022790023
177PhosphorylationEQDLGIQYKALKPEV
CCCCCCCHHHHCHHH
9.0525619855
178UbiquitinationQDLGIQYKALKPEVD
CCCCCCHHHHCHHHH
30.7622790023
181UbiquitinationGIQYKALKPEVDKLN
CCCHHHHCHHHHHHH
43.9522790023
186AcetylationALKPEVDKLNIMAAK
HHCHHHHHHHHHHHH
48.9223864654
193AcetylationKLNIMAAKRQQELKD
HHHHHHHHHHHHHHC
41.0023236377
193UbiquitinationKLNIMAAKRQQELKD
HHHHHHHHHHHHHHC
41.0022790023
216UbiquitinationAARGILQKNVPILYT
HHHHHHHHCCCEEEE
57.3722790023
225PhosphorylationVPILYTASQACLQHP
CCEEEECCHHHHHCC
15.5430352176
245PhosphorylationKANRDLIYKQLQQAV
HHCHHHHHHHHHHHH
10.4429514104
264PhosphorylationNAAQATASDDAAQHQ
HHHHHHCCCHHHHHC
31.5030352176
274PhosphorylationAAQHQGGSGGELAYA
HHHHCCCCHHHHHHH
50.9130352176
280PhosphorylationGSGGELAYALNNFDK
CCHHHHHHHHCCCCC
25.0126824392
295PhosphorylationQIIVDPLSFSEERFR
CEEECCCCCCHHHHC
31.9230352176
297PhosphorylationIVDPLSFSEERFRPS
EECCCCCCHHHHCCC
34.8630352176
304PhosphorylationSEERFRPSLEERLES
CHHHHCCCHHHHHHH
44.1222802335
323PhosphorylationAALMADSSCTRDDRR
HHHHCCCCCCCCHHH
21.7629899451
337GlutathionylationRERIVAECNAVRQAL
HHHHHHHHHHHHHHH
2.6024333276
391PhosphorylationKAVMDHVSDSFLETN
HHHHHHCCHHHHHCC
24.9023984901
393PhosphorylationVMDHVSDSFLETNVP
HHHHCCHHHHHCCCC
24.9923984901
397PhosphorylationVSDSFLETNVPLLVL
CCHHHHHCCCCEEHH
43.6023984901
417UbiquitinationNGNEKEVKEYAQVFR
CCCHHHHHHHHHHHH
46.2122790023
419PhosphorylationNEKEVKEYAQVFREH
CHHHHHHHHHHHHHH
9.1622499769
438GlutathionylationIEVANLACSISNNEE
HHHHHHHHHCCCCHH
4.1224333276
439PhosphorylationEVANLACSISNNEEG
HHHHHHHHCCCCHHH
24.3626824392
453PhosphorylationGVKLVRMSASQLEAL
HHEEEEECHHHHHHH
17.7626160508
455PhosphorylationKLVRMSASQLEALCP
EEEEECHHHHHHHHH
28.1726160508
461GlutathionylationASQLEALCPQVINAA
HHHHHHHHHHHHHHH
2.6024333276
478UbiquitinationLAAKPQSKLAQENMD
HHHCCHHHHHHHCHH
42.4622790023
499PhosphorylationEKQVRVLTDAVDDIT
HHHHHHHHHCCCCCC
21.0326239621
506PhosphorylationTDAVDDITSIDDFLA
HHCCCCCCCHHHHHH
26.9923984901
507PhosphorylationDAVDDITSIDDFLAV
HCCCCCCCHHHHHHH
25.1026824392
515PhosphorylationIDDFLAVSENHILED
HHHHHHHCCHHHHHH
27.3726370283
571UbiquitinationEPGVYTEKVLEATKL
CCCCCHHHHHHHHHH
44.3022790023
576PhosphorylationTEKVLEATKLLSNTV
HHHHHHHHHHHCCCC
16.9228059163
577UbiquitinationEKVLEATKLLSNTVM
HHHHHHHHHHCCCCC
55.2522790023
619PhosphorylationIDASRLVYDGIRDIR
CCHHHHHHHHHHHHH
17.0325263469
634PhosphorylationKAVLMIRTPEELDDS
HHHHCCCCHHHCCCC
24.9125521595
641PhosphorylationTPEELDDSDFETEDF
CHHHCCCCCCCCCCC
43.8127087446
645PhosphorylationLDDSDFETEDFDVRS
CCCCCCCCCCCCCCC
40.6324925903
652PhosphorylationTEDFDVRSRTSVQTE
CCCCCCCCCCCEECC
39.4927087446
654PhosphorylationDFDVRSRTSVQTEDD
CCCCCCCCCEECCCC
34.2027087446
655PhosphorylationFDVRSRTSVQTEDDQ
CCCCCCCCEECCCCC
15.8927087446
658PhosphorylationRSRTSVQTEDDQLIA
CCCCCEECCCCCCCC
38.9524925903
668PhosphorylationDQLIAGQSARAIMAQ
CCCCCHHHHHHHHHC
20.8525619855
681UbiquitinationAQLPQEQKAKIAEQV
HCCCHHHHHHHHHHH
51.3922790023
683UbiquitinationLPQEQKAKIAEQVAS
CCHHHHHHHHHHHHH
49.8622790023
690PhosphorylationKIAEQVASFQEEKSK
HHHHHHHHHHHHHHH
28.7130352176
695UbiquitinationVASFQEEKSKLDAEV
HHHHHHHHHHHHHHH
52.7322790023
695AcetylationVASFQEEKSKLDAEV
HHHHHHHHHHHHHHH
52.7323236377
697UbiquitinationSFQEEKSKLDAEVSK
HHHHHHHHHHHHHHH
62.5522790023
704UbiquitinationKLDAEVSKWDDSGND
HHHHHHHHCCCCCCH
60.8722790023
720S-palmitoylationIVLAKQMCMIMMEMT
HHHHHHHHHHHHHHC
1.2228680068
737UbiquitinationTRGKGPLKNTSDVIS
CCCCCCCCCHHHHHH
62.4022790023
747MalonylationSDVISAAKKIAEAGS
HHHHHHHHHHHHHHH
44.4126320211
747SuccinylationSDVISAAKKIAEAGS
HHHHHHHHHHHHHHH
44.4123954790
779PhosphorylationCKQDLLAYLQRIALY
HHHHHHHHHHHHHHH
11.8822668510
786PhosphorylationYLQRIALYCHQLNIC
HHHHHHHHHHHHCCH
4.4722668510
797UbiquitinationLNICSKVKAEVQNLG
HCCHHHHHHHHHHCC
42.4322790023
842UbiquitinationASYVASTKYQKSQGM
HHHHHCCCCCCCCCC
43.09-
842AcetylationASYVASTKYQKSQGM
HHHHHCCCCCCCCCC
43.0922647165
842MalonylationASYVASTKYQKSQGM
HHHHHCCCCCCCCCC
43.0926320211
845UbiquitinationVASTKYQKSQGMASL
HHCCCCCCCCCCCCC
41.4722790023
851PhosphorylationQKSQGMASLNLPAVS
CCCCCCCCCCCCHHC
14.65-
858PhosphorylationSLNLPAVSWKMKAPE
CCCCCHHCCCCCCCC
24.08-
860UbiquitinationNLPAVSWKMKAPEKK
CCCHHCCCCCCCCCC
24.0222790023
886PhosphorylationQTKIKRASQKKHVNP
HHHHHHHHHCCCCCH
46.71-
898PhosphorylationVNPVQALSEFKAMDS
CCHHHHHHHHHHHCC
43.9619367708
905PhosphorylationSEFKAMDSI------
HHHHHHCCC------
19.6727357545

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CTNA1_MOUSE !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CTNA1_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CTNA1_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CTNB1_MOUSECtnnb1physical
12695331
FMN1_MOUSEFmn1physical
14647292

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CTNA1_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry.";
Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
Mol. Cell. Proteomics 8:904-912(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY.
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry.";
Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.;
J. Proteome Res. 7:5314-5326(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY.
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis.";
Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
J. Proteome Res. 7:3957-3967(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641 AND SER-652, ANDMASS SPECTROMETRY.
"Large-scale phosphorylation analysis of mouse liver.";
Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-654; SER-655 ANDTHR-658, AND MASS SPECTROMETRY.
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations.";
Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.;
Mol. Cell. Proteomics 6:283-293(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY.
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry.";
Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.;
J. Proteome Res. 6:250-262(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY.
"Proteomic analysis of in vivo phosphorylated synaptic proteins.";
Collins M.O., Yu L., Coba M.P., Husi H., Campuzano I.,Blackstock W.P., Choudhary J.S., Grant S.G.;
J. Biol. Chem. 280:5972-5982(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-652 AND SER-655, ANDMASS SPECTROMETRY.
"Phosphoproteomic analysis of the developing mouse brain.";
Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.;
Mol. Cell. Proteomics 3:1093-1101(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641; THR-654 ANDTHR-658, AND MASS SPECTROMETRY.

TOP